BSI Proteomics + ArQule
Gaithersburg, Md.-based BSI Proteomics signed its first commercial partnership deal last week, agreeing to provide ArQule with three-dimensional structures of certain human ion channel proteins, the two companies said. ArQule, based in Woburn, Mass., will use the protein structures as part of its internal drug discovery program.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
